Synmosa Biopharma Corporation (TPEX:4114)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Active Pharmaceutical Ingredients Segment	467.25M	363.24M	325.78M	234.87M	119.57M
Active Pharmaceutical Ingredients Segment Growth	28.64%	11.50%	38.71%	96.43%	-21.63%
Generic Drugs Segment	6.00B	5.40B	4.96B	4.24B	3.15B
Generic Drugs Segment Growth	11.16%	8.78%	17.05%	34.70%	7.61%
Intersegment Income	-276.90M	-210.22M	-146.19M	-86.89M	-31.13M
Total	6.19B	5.55B	5.14B	4.39B	3.23B
Total Growth	11.53%	7.96%	17.19%	35.59%	6.47%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	5.24B	4.76B	4.45B	3.88B	2.81B
Taiwan Growth	10.01%	6.97%	14.83%	37.79%	7.43%
China	698.28M	564.55M	450.98M	271.73M	293.58M
China Growth	23.69%	25.18%	65.97%	-7.44%	-2.68%
United States	25.60M	2.21M	28.78M	62.74M	8.66M
United States Growth	1060.56%	-92.34%	-54.12%	624.84%	-
Canada	11.15M	2.14M	15.50M	34.97M	30.29M
Canada Growth	420.10%	-86.16%	-55.68%	15.43%	157.61%
Thailand	45.81M	29.70M	54.56M	39.60M	23.16M
Thailand Growth	54.23%	-45.56%	37.79%	70.99%	-10.52%
Malaysia	28.43M	34.36M	36.45M	30.75M	19.41M
Malaysia Growth	-17.24%	-5.73%	18.54%	58.38%	1.67%
Singapore	80.00M	75.89M	41.91M	-	-
Singapore Growth	5.43%	81.06%	-	-	-
Other	61.76M	79.11M	60.80M	70.10M	46.47M
Other Growth	-21.93%	30.12%	-13.28%	50.85%	-23.80%
Total	6.19B	5.55B	5.14B	4.39B	3.23B
Total Growth	11.53%	7.96%	17.19%	35.59%	6.47%

Source: S&P Global Market Intelligence.